Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
74.50
-0.75 (-1.00%)
Apr 29, 2026, 4:08 PM HKT

Keymed Biosciences Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Cash & Equivalents
503.35418.41851.03604.071,521
Upgrade
Short-Term Investments
1,1001,7371,6942,3391,951
Upgrade
Trading Asset Securities
319.940.24174.37232.1953.4
Upgrade
Cash & Short-Term Investments
1,9242,1562,7193,1753,525
Upgrade
Cash Growth
-10.76%-20.73%-14.37%-9.91%895.41%
Upgrade
Accounts Receivable
100.8563.7327.970.4810.55
Upgrade
Other Receivables
-51.0218.534.010.72
Upgrade
Receivables
100.85114.7546.4734.4911.27
Upgrade
Inventory
195.98123.9761.151.3322.43
Upgrade
Restricted Cash
39.59-1.78--
Upgrade
Other Current Assets
162.6871.711148.8323.67
Upgrade
Total Current Assets
2,4232,4662,9403,3103,582
Upgrade
Property, Plant & Equipment
1,2991,048893.74584.43177.53
Upgrade
Long-Term Investments
420.14210.0321.6320.5720.28
Upgrade
Other Intangible Assets
8.079.751.111.51.1
Upgrade
Other Long-Term Assets
67.1732.6626.9115.84153.59
Upgrade
Total Assets
4,2183,7673,8833,9323,934
Upgrade
Accounts Payable
28.0626.0129.4914.912.78
Upgrade
Accrued Expenses
-118.39113.290.9949.93
Upgrade
Short-Term Debt
-337.1813.0160.790.55
Upgrade
Current Portion of Long-Term Debt
509.37135.1932.810.6-
Upgrade
Current Portion of Leases
9.5212.3619.4311.0811.72
Upgrade
Current Income Taxes Payable
2.734.971.821.030.94
Upgrade
Current Unearned Revenue
0.451.58--1.61
Upgrade
Other Current Liabilities
286.17112.05104.42200.344.54
Upgrade
Total Current Liabilities
836.29747.73314.18379.7112.08
Upgrade
Long-Term Debt
258.03257.19331.8328.8-
Upgrade
Long-Term Leases
11.6211.3221.6220.9326.99
Upgrade
Long-Term Unearned Revenue
336.67274.78228.19163.678.72
Upgrade
Long-Term Deferred Tax Liabilities
-0.350.28--
Upgrade
Other Long-Term Liabilities
----141.29
Upgrade
Total Liabilities
1,4431,291896.11593.1289.07
Upgrade
Common Stock
0.20.170.170.170.17
Upgrade
Additional Paid-In Capital
-8,4968,4848,4858,516
Upgrade
Retained Earnings
--6,165-5,649-5,290-4,982
Upgrade
Treasury Stock
-0-0---
Upgrade
Comprehensive Income & Other
2,774143.07151.76144.97116.82
Upgrade
Total Common Equity
2,7742,4752,9863,3403,651
Upgrade
Minority Interest
0.670.640.5-1.07-5.59
Upgrade
Shareholders' Equity
2,7752,4752,9873,3393,645
Upgrade
Total Liabilities & Equity
4,2183,7673,8833,9323,934
Upgrade
Total Debt
788.54753.24418.71122.1939.26
Upgrade
Net Cash (Debt)
1,1351,4022,3003,0533,485
Upgrade
Net Cash Growth
-19.05%-39.04%-24.65%-12.40%-
Upgrade
Net Cash Per Share
4.145.358.8011.6921.67
Upgrade
Filing Date Shares Outstanding
283.64275.6276.6277.39279.74
Upgrade
Total Common Shares Outstanding
283.64275.6276.6277.39279.74
Upgrade
Working Capital
1,5871,7182,6252,9303,470
Upgrade
Book Value Per Share
9.788.9810.8012.0413.05
Upgrade
Tangible Book Value
2,7662,4652,9853,3393,650
Upgrade
Tangible Book Value Per Share
9.758.9410.7912.0413.05
Upgrade
Buildings
-190.16190.16--
Upgrade
Machinery
-692.07626.77235.49110.64
Upgrade
Construction In Progress
-213.9334.48323.5521.63
Upgrade
Leasehold Improvements
-62.0560.7751.7342.45
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.